Hsbc Holdings PLC Tricida, Inc. Transaction History

Hsbc Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$7.31 - $11.85 $74,766 - $121,201	-10,228 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.56 - $4.64 $36,411 - $47,457	10,228 New	10,228 $47,000
Q3 2020 Nov 12, 2020	SELL	$8.56 - $26.93 $72,537 - $228,204	-8,474 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$21.21 - $31.55 $179,733 - $267,354	8,474 New	8,474 $233,000
Q1 2020 May 15, 2020	SELL	$18.43 - $38.04 $134,612 - $277,844	-7,304 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$29.6 - $43.71 $216,198 - $319,257	7,304 New	7,304 $276,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.